AstraZeneca issues updated phase three trial data for its Covid vaccine after facing criticism ...United Arab Emirates

CNBC - Economy
AstraZeneca issues updated phase three trial data for its Covid vaccine after facing criticism
The company now says its vaccine is 76% effective in protecting against symptomatic cases of virus.

Hence then, the article about astrazeneca issues updated phase three trial data for its covid vaccine after facing criticism was published today ( ) and is available on CNBC ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( AstraZeneca issues updated phase three trial data for its Covid vaccine after facing criticism )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy